APA (7th ed.) Citation

H, X., S, L., F, L., O, F., P, L., E, S., . . . JL, T. (2026). RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma. BioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.01.07.698153

Chicago Style (17th ed.) Citation

H, Xu, et al. "RIG-I RNA Agonist Activates Immunostimulatory Macrophages to Enhance Checkpoint Immunotherapy for Glioblastoma." BioRxiv : The Preprint Server for Biology 2026. https://doi.org/10.64898/2026.01.07.698153.

MLA (9th ed.) Citation

H, Xu, et al. "RIG-I RNA Agonist Activates Immunostimulatory Macrophages to Enhance Checkpoint Immunotherapy for Glioblastoma." BioRxiv : The Preprint Server for Biology, 2026, https://doi.org/10.64898/2026.01.07.698153.